KISQALI (ribociclib) tablets. FDA-Approved

KISQALI (ribociclib) tablets can be ordered by patient or doctor, if the drug has not been approved or is not available in your country. Medvitaz Pharma Solutions can help you from India to get best price/cost of KISQALI (ribociclib) tablets to Breast cancer.
Categories: , .

KISQALI (ribociclib) tablets. FDA-Approved

What is FDA-approved KISQALI (ribociclib) tablets indicated for?

KISQALI (ribociclib) tablets is a prescription medicine. KISQALI (ribociclib) tablets is used to treat Ovarian cancer and Breast cancer.
INDICATIONS AND USAGE
KISQALI is a kinase inhibitor indicated in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.
DOSAGE FORMS & STRENGTHS
Tablets: 200 mg
Manufactured By: Novartis Pharmaceuticals Corporation
Prescribing Information URL: Click Here

How to make an enquiry for KISQALI (ribociclib) tablets?

Anticancer medicine KISQALI (ribociclib) tablets available upon request. To get best price in india, Call 9811747774 or Email info@medvitaz.com to discuss advanced treatments with Breast Cancer Specialists in India without travel. Medvitaz Pharma Solutions can help you to get genuine, affordable and assurance of delivery of approved medicines for Breast Cancer and Ovarian Cancer.

What Ribociclib is indicated for?

Ribociclib, sold under the brand name Kisqali, is an inhibitor of cyclin D1/CDK4 and CDK6, and is used for the treatment of certain kinds of breast cancer. It is also being studied as a treatment for other drug-resistant cancers. It was developed by Novartis and Astex Pharmaceuticals.

Ribociclib was approved by the U.S. Food and Drug Administration (FDA) in March 2017, and the European Medicines Agency (EMA) in August 2017, for use in combination with an aromatase inhibitor (such as letrozole) to treat HR-positive, HER2-negative advanced or metastatic breast cancers.

In the clinical trial relevant for the drug's approval, ribociclib significantly improved progression-free survival (PFS), that is, the time span the cancer did not get worse. For patients receiving placebo plus letrozole, PFS was 16 months on average, while under ribociclib plus letrozole, PFS was 25 months as of the January 2017 analysis.

How and where to buy KISQALI (ribociclib) tablets?

You can order KISQALI (ribociclib) tablets from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery of approved medicines for Breast Cancer and Ovarian Cancer. To get best price/cost of KISQALI (ribociclib) tablets in India, Call 8750295029 or Email urgent@medvitaz.com

Reviews

There are no reviews yet.

Add a review

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.